EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Clinical and mechanistic advancements in aspirin exacerbated respiratory disease

Shabnam Elahi, Anju T Peters, Atsushi Kato, Whitney W Stevens

Journal of Allergy and Clinical Immunology · 2025-05 · 155 (5) · 1411-1419

DOI: 10.1016/j.jaci.2025.03.006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025-05. Verfasst von Shabnam Elahi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, Ill. Hauptthemen laut MEDLINE: Aspirin, Asthma, Aspirin-Induced, Nasal Polyps, Sinusitis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aspirin-exacerbated respiratory disease (AERD) is characterized by the clinical triad of chronic rhinosinusitis with nasal polyps, asthma, and a hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs). AERD is estimated to occur in as many as 15% of patients with chronic rhinosinusitis with nasal polyps and/or asthma. Uniquely, patients with AERD develop respiratory symptoms within 30 to 180 minutes after ingesting NSAIDs such as aspirin or ibuprofen. However, even in the absence of NSAIDs, patients tend to have more severe upper and lower respiratory disease. The underlying pathogenic mechanisms contributing to AERD are complex and intertwined; they include a systemic dysregulation in arachidonic acid metabolism, an aberrant inflammatory response, a disruption in the respiratory epithelial barrier, and an imbalance between the formation and degradation of fibrin locally in nasal polyps. This review will highlight novel mechanistic findings contributing to the pathogenesis of AERD. In addition, recent advancements in the clinical understanding and management of patients with AERD will be discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspirinAsthma, Aspirin-InducedNasal PolypsSinusitisAnti-Inflammatory Agents, Non-SteroidalRhinitisHumansAnimals

Stichwörter der Autor:innen

AERDNSAID-ERDbiologicsbiologics. CRSwNPmechanismsnasal polypsnatural historytreatment

Substanzen

AspirinAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, Ill.
  • Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, Ill. Electronic address: whitney-stevens@northwestern.edu.

Förderung

  • NIAID NIH HHS
  • NIH

Zitieren

APA

Elahi, S., Peters, A. T., Kato, A., & Stevens, W. W. (2025). Clinical and mechanistic advancements in aspirin exacerbated respiratory disease. Journal of Allergy and Clinical Immunology, 155(5), 1411-1419. https://doi.org/10.1016/j.jaci.2025.03.006

Vancouver

Elahi S, Peters AT, Kato A, Stevens WW. Clinical and mechanistic advancements in aspirin exacerbated respiratory disease. Journal of Allergy and Clinical Immunology. 2025;155(5):1411-1419. doi:10.1016/j.jaci.2025.03.006

BibTeX
@article{Elahi2025,
  author = {Elahi, Shabnam and Peters, Anju T and Kato, Atsushi and Stevens, Whitney W},
  title = {Clinical and mechanistic advancements in aspirin exacerbated respiratory disease},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2025},
  volume = {155},
  number = {5},
  pages = {1411--1419},
  doi = {10.1016/j.jaci.2025.03.006}
}
Kostenlos starten →